These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3583474)

  • 1. AIDS and self-organization among intravenous drug users.
    Friedman SR; Des Jarlais DC; Sotheran JL; Garber J; Cohen H; Smith D
    Int J Addict; 1987 Mar; 22(3):201-19. PubMed ID: 3583474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS health education for intravenous drug users.
    Friedman SR; Des Jarlais DC; Sotheran JL
    Health Educ Q; 1986; 13(4):383-93. PubMed ID: 3781862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction theory: users' culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users' groups.
    Friedman SR; de Jong W; Rossi D; Touzé G; Rockwell R; Des Jarlais DC; Elovich R
    Int J Drug Policy; 2007 Mar; 18(2):107-17. PubMed ID: 17689353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.
    Des Jarlais DC; Friedman SR; Hopkins W
    Ann Intern Med; 1985 Nov; 103(5):755-9. PubMed ID: 4051350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV and intravenous drug use.
    Des Jarlais DC; Friedman SR
    AIDS; 1988; 2 Suppl 1():S65-9. PubMed ID: 3147682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.
    Selwyn PA; Feiner C; Cox CP; Lipshutz C; Cohen RL
    AIDS; 1987 Dec; 1(4):247-54. PubMed ID: 3126773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of acquired immune deficiency syndrome in intravenous drug users.
    Shine D
    Adv Alcohol Subst Abuse; 1985 Fall-1986 Winter; 5(1-2):25-34. PubMed ID: 3832900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection among intravenous drug users: epidemiology and risk reduction.
    Des Jarlais DC; Friedman SR
    AIDS; 1987 Jul; 1(2):67-76. PubMed ID: 3130084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of the acquired immunodeficiency syndrome in intravenous drug abusers.
    Koplan JP; Hardy AM; Allen JR
    Adv Alcohol Subst Abuse; 1985 Fall-1986 Winter; 5(1-2):13-23. PubMed ID: 3879573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous drug users and the acquired immune deficiency syndrome.
    Ginzburg HM
    Public Health Rep; 1984; 99(2):206-12. PubMed ID: 6424170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of needle sharing among intravenous drug users.
    Magura S; Grossman JI; Lipton DS; Siddiqi Q; Shapiro J; Marion I; Amann KR
    Am J Public Health; 1989 Apr; 79(4):459-62. PubMed ID: 2784636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection among persons who inject illicit drugs: problems and prospects.
    Des Jarlais DC; Friedman SR
    J Acquir Immune Defic Syndr (1988); 1988; 1(3):267-73. PubMed ID: 3216310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social intervention against AIDS among injecting drug users.
    Friedman SR; Neaigus A; Des Jarlais DC; Sotheran JL; Woods J; Sufian M; Stepherson B; Sterk C
    Br J Addict; 1992 Mar; 87(3):393-404. PubMed ID: 1559038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AIDS epidemic in New York City, 1981-1984. New York City Department of Health AIDS Surveillance.
    Am J Epidemiol; 1986 Jun; 123(6):1013-25. PubMed ID: 3706272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experiential program to reduce AIDS risk among female sex partners of injection-drug users.
    Rhodes F; Wolitski RJ; Thornton-Johnson S
    Health Soc Work; 1992 Nov; 17(4):261-72. PubMed ID: 1478552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Free" needles for intravenous drug users at risk for AIDS: current developments in New York City.
    Des Jarlais DC; Hopkins W
    N Engl J Med; 1985 Dec; 313(23):1476. PubMed ID: 4058552
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS and the new drug injector.
    Friedman SR; Des Jarlais DC; Neaigus A; Abdul-Quader A; Sotheran JL; Sufian M; Tross S; Goldsmith D
    Nature; 1989 Jun; 339(6223):333-4. PubMed ID: 2725656
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention.
    Des Jarlais DC; Friedman SR; Stoneburner RL
    Rev Infect Dis; 1988; 10(1):151-8. PubMed ID: 3281219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City.
    Stoneburner RL; Des Jarlais DC; Benezra D; Gorelkin L; Sotheran JL; Friedman SR; Schultz S; Marmor M; Mildvan D; Maslansky R
    Science; 1988 Nov; 242(4880):916-9. PubMed ID: 3187532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Collective of users in the fields of AIDS and drug addiction].
    Broqua C; Jauffret-Roustide M
    Med Sci (Paris); 2004 Apr; 20(4):475-9. PubMed ID: 15124122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.